72
Participants
Start Date
September 1, 2018
Primary Completion Date
December 1, 2025
Study Completion Date
December 1, 2025
Inhaled budesonide
Patients will use inhaled budesonide (Numark) with space chamber at 400 mcg given twice daily initiating after the first dose of RT and continuing until pneumonitis development or 12 months completed.
RECRUITING
Instituto Nacional de Cancerologia, Mexico City
ACTIVE_NOT_RECRUITING
Instituto Nacional de Enfermedades Respiratorias, Mexico City
Instituto Nacional de Enfermedades Respiratorias
OTHER_GOV
Instituto Nacional de Cancerologia de Mexico
OTHER